BREAKING
Protagonist Therapeutics Jumps 7.0% in Broad Rally 11 hours ago Valaris Limited Drops 6.7% in Broad Selloff 12 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 12 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 12 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 13 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 13 hours ago Celanese Corporation Shares Dropping 5.5% 13 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 13 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 13 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 13 hours ago Protagonist Therapeutics Jumps 7.0% in Broad Rally 11 hours ago Valaris Limited Drops 6.7% in Broad Selloff 12 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 12 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 12 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 13 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 13 hours ago Celanese Corporation Shares Dropping 5.5% 13 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 13 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 13 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 13 hours ago
ADVERTISEMENT
AlphaGraphs

Walgreens Boots Alliance (WBA) Q4 2023 Earnings: Key financials and quarterly highlights

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported fourth quarter 2023 earnings results today. Sales increased 9.2% year-over-year to $35.4 billion. Sales growth was 8.3% on a constant currency basis. The top line increase was driven by growth in the US Retail Pharmacy and International segments, and sales contribution from the US Healthcare segment. Net loss […]

October 12, 2023 1 min read

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported fourth quarter 2023 earnings results today. Sales increased 9.2% year-over-year to $35.4 billion. Sales growth was 8.3% on a constant currency basis. The top line increase was driven by growth in the US Retail Pharmacy and International segments, and sales contribution from the US Healthcare segment. Net loss […]

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported fourth quarter 2023 earnings results today.

Sales increased 9.2% year-over-year to $35.4 billion. Sales growth was 8.3% on a constant currency basis. The top line increase was driven by growth in the US Retail Pharmacy and International segments, and sales contribution from the US Healthcare segment.

Net loss was $180 million, or $0.21 per share, compared to a loss of $415 million, or $0.48 per share, last year. Adjusted EPS decreased 17% to $0.67.  

The company expects adjusted EPS of $3.20-3.50 in fiscal year 2024.

Prior performance

ADVERTISEMENT